Vaxcyte Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Vaxcyte Inc
Current Price
$55.95
+0.56%Profile
Valuation (TTM)
Market Cap$7.28B
P/E-9.50
EV—
P/B2.71
Shares Out130.18M
P/Sales—
Revenue$0.00
EV/EBITDA—
Vaxcyte Inc (PCVX) Stock Analysis
Market Cap$7.28B
Current Price$55.95
P/E Ratio-9.50
Forward P/E—
PEG Ratio-0.12
EPS$-5.63
Book Value$20.63
P/B Ratio2.71
PCVX Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 56M
Revenue
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
Net Income
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
PCVX 52-Week Range
$29.00
$63.04
50-Day MA: $58.61200-Day MA: $46.39
Did you know?
Price sits at 79% of its 52-week range.
Vaxcyte Inc (PCVX) Financial Summary
Vaxcyte Inc (PCVX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. The stock currently trades at $55.95 with a market capitalization of $7.28B.
Key valuation metrics include a P/E ratio of -9.50, price-to-book ratio of 2.71, and EPS of $-5.63. and return on equity of -28.5%.
PCVX Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $7.28B |
| P/E Ratio | -9.50 |
| EPS | $-5.63 |
| P/B Ratio | 2.71 |
| Return on Equity | -28.5% |
| Debt/Equity | 0.04 |
PCVX Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $0.00 | $-50.27M |
| FY20 | $0.00 | $-89.22M |
| FY21 | $0.00 | $-100.08M |
| FY22 | $0.00 | $-223.49M |
| FY23 | $0.00 | $-402.27M |
| FY24 | $0.00 | $-463.93M |
| FY25 | $0.00 | $-766.63M |
About Vaxcyte Inc
Vaxcyte Inc
PCVX Free Cash Flow
Vaxcyte Inc generated $-712.55M in trailing twelve-month free cash flow, representing an FCF yield of -9.78%. This low FCF yield may reflect heavy reinvestment or growth spending.
PCVX Shares Outstanding
Vaxcyte Inc has 0.13 billion shares outstanding at a share price of $55.95, giving it a market capitalization of $7.28B.